Expecting startup year /2020
No. of team members /5
Name /Jason Brenker
Telephone /(Work) +61 431196889
Mobile /+61 431196889
We are an interdisciplinary team, which brings together expertise in engineering, design, pharmacy and respiratory medicine from three different institutions (Monash University, University of Sydney and Swinburne University).
The core team combines expertise in microfluidic droplet ejection, nanofabrication (Jason Brenker & Tuncay Alan) and respiratory drug delivery, in vitro studies and repurposing (Daniela Traini), biologicals and respiratory models (Hui Xin Ong), immunology and respiratory medicine (Bruce Thompson), and industrial design (Daphne Flynn). We have a state- of- the- art laboratory and with access to specialised instrumentation for the optimisation of the microfluidic components and device integration and pharmaceutical characterisation.
PALM (Personalised Aerosol Loading and Management) Breather is a portable aerosol drug delivery platform. It employs a small form-factor device, which sits comfortably in the palm of the hand, and fits a variety of face shapes thanks to its universal design (design registration pending). The device uses disposable microfluidic chips to dial the size, distribution and dose of aerosolised particles on-demand. This represents a first for targeted, personalised inhalation therapy that is tuneable for pulmonary and nasal administration of therapeutics from a single device. A PCT patent application (PCT/AU2019/050778) was recently filed in the name of Monash University. We have a portable integrated aerosol system, which can address the specific needs of patients, for the specific delivery route. We are currently gathering pre-clinical data from our prototypes and progressing towards commercialization with the aim of beginning clinical trials within the next year.